Dexcom's CGM and Abbott's FreeStyle Libre are ... CGMs consist of a sensor, a transmitter, and a receiver. The sensor is ...

Looking at the results in more detailed, we can see that Dexcom struggled, especially in the United States. Revenue declined 1.6% year-over-year from $713.6 million in Q3/23 to $701.9 million in ...

DexCom's Q2 earnings report was disastrous, revealing internal sales channel issues and competitive pressures, leading to a Hold rating and lowered price targets. The company's reliance on channel ...

Over the past five years, diabetes-focused medical device specialist DexCom (NASDAQ: DXCM) has made meaningful progress on several fronts. The company launched new products in the continuous ...

DexCom will likely make significant headway in its addressable market in the next five years. The company should also increase its reach by launching new products and entering new countries ...

Reporting its third-quarter results after market hours Thursday, DexCom said its revenue amounted to $994 million for the period. This was, however, only 2% higher on a year-over-year basis for ...

View all Key Company Metrics for DexCom here>>> Shares of DexCom have returned +8.6% over the past month versus the Zacks S&P 500 composite's +1.5% change. The stock currently has a Zacks Rank #4 ...

In reaction to the news, DXCM stock plunged over 40.6% on July 26. To conclude, DexCom allegedly misled investors about its revenue growth prospects for Fiscal 2024. Year-to-date, DXCM stock has ...

Amid the launch of its first over-the-counter wearable glucose tracker, Dexcom reported that its overall revenues in the U.S. declined year over year despite overall sales coming in slightly ...

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...